Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History AMED

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics AMED

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Amedisys Inc

AMED
Current price
97.84 USD +0.34 USD (+0.35%)
Last closed 97.46 USD
ISIN US0234361089
Sector Healthcare
Industry Medical Care Facilities
Exchange NASDAQ
Capitalization 3 198 598 144 USD
Yield for 12 month +6.75 %
1Y
3Y
5Y
10Y
15Y
AMED
21.11.2021 - 28.11.2021

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana. Address: 3854 American Way, Baton Rouge, LA, United States, 70816

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

97.38 USD

P/E ratio

35.96

Dividend Yield

Financials AMED

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures AMED

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+2 348 324 000 USD

Last Year

+2 236 382 000 USD

Current Quarter

+594 781 000 USD

Last Quarter

+598 052 000 USD

Current Year

+1 017 677 000 USD

Last Year

+990 873 000 USD

Current Quarter

+260 731 000 USD

Last Quarter

+253 438 000 USD
EBITDA 244 096 992 USD
Operating Margin TTM 10.11 %
Price to Earnings 35.96
Return On Assets TTM 6.36 %
PEG Ratio 1.42
Return On Equity TTM 7.15 %
Wall Street Target Price 97.38 USD
Revenue TTM 2 371 691 008 USD
Book Value 36.55 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 4.10 %
Dividend Yield
Gross Profit TTM 1 028 531 008 USD
Earnings per share 2.71 USD
Diluted Eps TTM 2.71 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 318.20 %
Profit Margin 3.79 %

Stock Valuation AMED

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 35.96
Forward PE 21.37
Enterprise Value Revenue 1.43
Price Sales TTM 1.35
Enterprise Value EBITDA 14.06
Price Book MRQ 2.68

Technical indicators AMED

For 52 weeks

82.15 USD 98.95 USD
50 Day MA 94.37 USD
Shares Short Prior Month 2 024 273
200 Day MA 93.15 USD
Short Ratio 4.91
Shares Short 1 878 352
Short Percent 5.82 %